Invention Grant
- Patent Title: EML4-ALK translocations in lung cancer
-
Application No.: US16594718Application Date: 2019-10-07
-
Publication No.: US11639529B2Publication Date: 2023-05-02
- Inventor: Heather R. Sanders , Maher Albitar , Aurelia Meloni-Ehrig
- Applicant: Quest Diagnostics Investments LLC
- Applicant Address: US NJ Secaucus
- Assignee: Quest Diagnostics Investments LLC
- Current Assignee: Quest Diagnostics Investments LLC
- Current Assignee Address: US NJ Secaucus
- Agency: Foley & Lardner LLP
- Main IPC: C12Q1/6886
- IPC: C12Q1/6886 ; C07K16/40 ; C12Q1/48
Abstract:
The present disclosure relates to methods for the diagnosis and evaluation of neoplastic disorders, particularly non-small cell lung cancer. Assays are described in which patient test samples are analyzed for the presence of one or more specific EML4-ALK fusion genes associated with neoplastic disorders.
Information query
IPC分类:
